Literature DB >> 15614702

Nonantimicrobial effects of antibacterial agents.

Timothy R Pasquale1, James S Tan.   

Abstract

One of the major advances in modern medicine was the development of antimicrobial chemotherapy. However, many antibacterial agents have unexpected or undesirable nonantimicrobial effects on humans. Microbes and man share many essentials of life, including DNA, adenosine triphosphate, and other biochemical pathways. Hence, some of these nonantimicrobial effects may also turn out to be pharmacologically useful. Oral hypoglycemic agents (i.e., sulfonylureas) and a certain diuretic agent (acetazolamide) are derivatives of sulfonamides. Erythromycin has been used clinically for its stimulatory effect on gastrointestinal motility. Macrolides, lincosamides, and tetracyclines have been known for their immunomodulatory effects. A tetracycline has been used to treat the syndrome of inappropriate antidiuretic hormone. Aminoglycosides may influence mucus production in patients with cystic fibrosis. Other antimicrobials may have side effects that are not therapeutically useful, such as osmotic diuresis with high-dose beta -lactam administration, neuromuscular blockade of aminoglycosides, dysglycemia of fluoroquinolones, and serotonin syndrome with oxazolidinones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614702     DOI: 10.1086/426545

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Rifampin augments cytokine-induced nitric oxide production in human alveolar epithelial cells.

Authors:  Yael Yuhas; Eva Berent; Hila Ovadiah; Inbar Azoulay; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  The immune response and antibacterial therapy.

Authors:  Olachi Anuforom; Graham R Wallace; Laura V Piddock
Journal:  Med Microbiol Immunol       Date:  2014-09-05       Impact factor: 3.402

Review 4.  Gut microbiota impact on stroke outcome: Fad or fact?

Authors:  Katarzyna Winek; Andreas Meisel; Ulrich Dirnagl
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

Review 5.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 6.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 7.  Nervous system effects of antituberculosis therapy.

Authors:  Joseph S Kass; Wayne X Shandera
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

8.  Chemical modulators of the innate immune response alter gypsy moth larval susceptibility to Bacillus thuringiensis.

Authors:  Nichole A Broderick; Kenneth F Raffa; Jo Handelsman
Journal:  BMC Microbiol       Date:  2010-04-27       Impact factor: 3.605

Review 9.  [Topical and novel device-based therapies for mild hidradenitis suppurativa].

Authors:  G Nikolakis; E von Stebut
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751

10.  Roles of NF-kappaB activation and peroxisome proliferator-activated receptor gamma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells.

Authors:  Yael Yuhas; Eva Berent; Regev Cohen; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2008-12-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.